Who May File a Medical Device Registration Application in Russia: Applicant Eligibility Rules

1. Key takeaways

A foreign manufacturer of medical devices is not eligible to submit a registration application to RZN directly. The application must be filed by an entity holding the proper status, and in practice this role is performed by the authorized representative of the manufacturer established in Russia (upolnomochenny predstavitel izgotovitelya). This structure runs through the entire product lifecycle: later amendments, vigilance communications and on-site inspections are all handled through the same authorized representative. Understanding who may act as the applicant is therefore the first structural decision in any Russian market-entry project, and it shapes the drafting of the power of attorney, the service agreements and the allocation of regulatory responsibilities between the manufacturer, its representative and any importer.

Two further points matter for planning. First, the restriction applies at the registration stage only: once a device is registered, the law does not limit which entity may import it. Second, the applicant role and the import role can be held by different entities, provided the split of duties is documented. Confusing these two questions is the most common source of avoidable delay and compliance exposure for foreign manufacturers entering Russia.

2. Legal basis

The applicant rule rests on a small set of federal instruments. The table below lists the acts relied on in this article, with their reference numbers, dates and the specific provisions that govern the applicant qualification and the confirmation documents for the authorized representative.

3. Expert insights

Insight one: the restriction at the registration stage is not a restriction on circulation. The interpretation set out in Letter No. 01И-171/08 is that once a device has completed state registration, any entity has the right to import, sell and use it. The frequent misunderstanding that only the registration holder may import is therefore incorrect. What needs to be distinguished with precision is who may submit the registration application and who may physically bring the goods into the country. These are separate legal questions governed by separate rules, and conflating them leads to poorly drafted agreements and to unnecessary anxiety about market access after the certificate has been issued.

Insight two: the authorized representative appointment is a long-term legal relationship, not a one-off delegation. The details of the representative enter the registration dossier and the national register. Any change to those details is processed as a change to the registration dossier. An improper replacement of the representative can trigger suspension and revocation procedures. For this reason the choice of the representative deserves the same level of diligence as the choice of a distributor, and the appointment documents should be drafted with the full lifecycle in mind rather than only the initial filing.

Insight three: the applicant identity and the import arrangement can be separated. The authorized representative is responsible for registration and for regulatory communications, while the importer handles customs clearance and the batch-by-batch notification obligations established under Order No. 11020. When these two roles are performed by different entities, the allocation of responsibilities must be written into the agreements. A written split protects the manufacturer in disputes, clarifies who responds to regulator queries about a specific shipment, and prevents gaps in the flow of information about adverse events and field safety actions.

Insight four: early structuring saves rework. Because the representative details are embedded in the register, switching representatives later means a formal dossier amendment with its own timeline and fees. Companies that select a stable, professionally managed representative at the outset avoid a second amendment cycle, and the power of attorney should be drafted broadly enough to cover foreseeable future product lines so that new certificates do not require a fresh appointment each time.

4. Practical recommendations

The following actions help foreign manufacturers set up a compliant and durable applicant structure in Russia. They reflect the provisions summarized above and the practical experience of registration projects conducted under the current national rules.

1. Appoint the authorized representative before dossier preparation starts, so that all application forms, declarations and correspondence carry the correct applicant details from day one.
2. In the appointment agreement, list the scope of the representative’s powers, response deadlines, the return of materials and the terms of termination.
3. Draft the power of attorney to contain an express authorization for the circulation of the manufacturer’s medical devices in the territory of the Russian Federation, and have a notarized Russian translation prepared.
4. When the representative and the importer are separate entities, define in writing how adverse event information is aggregated and routed, so that no link in the information chain is broken.
5. Record in the internal register which entity holds which duty, and review the allocation annually against the actual flow of shipments and regulator correspondence.

5. Verification checklist

Before filing, confirm each item below. Any unchecked item indicates a gap that is likely to surface during the dossier completeness review.

• □ The applicant is a Russian local entity and its qualification is valid at the time of filing
• □ The power of attorney for the authorized representative has been notarized and translated into Russian
• □ The boundary of duties between the representative and the importer is stated in the agreements
• □ The importer understands the batch-by-batch notification obligation under Order No. 11020
• □ A replacement plan for the representative has been incorporated into change management

Regulatory information verified as of 29 October 2026.

GRZAN supports foreign medical device manufacturers entering Russia as a local authorized representative and importer of record. Its team prepares and files registration applications, manages regulator communications, maintains the applicant structure across the product lifecycle and builds itemized budgets for registration and import costs, including state fees, testing and logistics. For a scoped proposal, contact GRZAN at info@grzanglobal.com.